A detailed history of Blair William & CO transactions in Natera, Inc. stock. As of the latest transaction made, Blair William & CO holds 5,716 shares of NTRA stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,716
Previous 2,717 110.38%
Holding current value
$1.17 Million
Previous $459,000 100.44%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$133.66 - $181.11 $400,846 - $543,148
2,999 Added 110.38%
5,716 $920,000
Q2 2025

Jul 24, 2025

BUY
$132.23 - $171.87 $3,437 - $4,468
26 Added 0.97%
2,717 $459,000
Q4 2024

Feb 12, 2025

BUY
$117.67 - $174.0 $316,649 - $468,234
2,691 New
2,691 $425,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.